Tremor in Parkinson's Disease

Bart E. K. S. Swinnen; Arthur W. G. Buijink; Alberto J. Espay; Rob M. A. de Bie

doi:10.1055/a-2768-3003

Seminars in Neurology, Inhaltsverzeichnis

Semin Neurol
DOI: 10.1055/a-2768-3003

Review Article

Tremor in Parkinson's Disease

Autor*innen

Bart E. K. S. Swinnen

¹Department of Neurology, University Hospitals Leuven, Leuven, Belgium

²Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands
Arthur W. G. Buijink

²Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands
Alberto J. Espay

³Department of Neurology, James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, University of Cincinnati, Cincinnati, Ohio, United States
Rob M. A. de Bie

²Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands

Abstract

Tremor is one of the most visible and distressing symptoms of Parkinson's disease (PD), ranking high among patients' most bothersome features. While levodopa is the most effective pharmacological therapy, approximately half of patients report insufficient tremor control, and refractory tremor remains a major therapeutic challenge. The psychosocial impact of tremor is profound: its visibility leads to embarrassment, stigma, and emotional distress, while its interference with daily activities and professional life compounds disability. Prevalence studies suggest that nearly all individuals with PD experience tremor at some point, though its severity fluctuates over time and may plateau or improve in later disease stages. Tremor pathophysiology differs from bradykinesia and rigidity, involving both basal ganglia and cerebello-thalamo-cortical circuits, supporting the “dimmer-switch” model. Management strategies include dopaminergic and nondopaminergic medications, deep brain stimulation, and emerging interventions such as MR-guided focused ultrasound. Optimizing therapy remains crucial to alleviating tremor-related burden in PD.

Keywords

PD - tremor - pathophysiology - treatment

Volltext

Referenzen

References
1 Lerner A, Mammen JR, Tyo M. et al. Fox insight: most bothersome symptoms in early-stage Parkinson's disease. Mov Disord Clin Pract 2024; 2025: 1-6
2 Politis M, Wu K, Molloy S, GBain P, Chaudhuri KR, Piccini P. Parkinson's disease symptoms: the patient's perspective. Mov Disord 2010; 25 (11) 1646-1651
3 Hauser RA, Skarpaas TC, Merriam A. et al. Burden of tremor in Parkinson's disease: A survey study. J Parkinsons Dis 2025; 15 (03) 541-551
4 Port RJ, Rumsby M, Brown G, Harrison IF, Amjad A, Bale CJ. People with Parkinson's disease: what symptoms do they most want to improve and how does this change with disease duration?. J Parkinsons Dis 2021; 11 (02) 715-724
5 Heusinkveld LE, Hacker ML, Turchan M, Davis TL, Charles D. Impact of tremor on patients with early stage Parkinson's disease. Front Neurol 2018; 9 (628) 628
6 Hou M, Mao X, Hou X, Li K. Stigma and associated correlates of elderly patients with Parkinson's disease. Front Psychiatry 2021; 12 (708960): 708960
7 Pirker W, Katzenschlager R, Hallett M, Poewe W. Pharmacological treatment of tremor in Parkinson's disease revisited. J Parkinsons Dis 2023; 13 (02) 127-144
8 Louis ED. More time with tremor: the experience of essential tremor versus Parkinson's disease patients. Mov Disord Clin Pract 2016; 3 (01) 36-42
9 Zhou H, Shen C, Chen J. et al. Tremor and clinical fluctuation are related to sleep disorders in Chinese patients with Parkinson's disease. Transl Neurodegener 2014; 3 (01) 21
10 Louis ED, Machado DG. Tremor-related quality of life: a comparison of essential tremor vs. Parkinson's disease patients. Parkinsonism Relat Disord 2015; 21 (07) 729-735
11 Pasquini J, Deuschl G, Pecori A, Salvadori S, Ceravolo R, Pavese N. The clinical profile of tremor in Parkinson's disease. Mov Disord Clin Pract 2023; 10 (10) 1496-1506
12 Louis ED, Levy G, Côte LJ, Mejia H, Fahn S, Marder K. Clinical correlates of action tremor in Parkinson disease. Arch Neurol 2001; 58 (10) 1630-1634
13 Kim HT, Edwards MJ, Lakshmi Narsimhan R, Bhatia KP. Hyperthyroidism exaggerating Parkinsonian tremor: a clinical lesson. Parkinsonism Relat Disord 2005; 11 (05) 331-332
14 Minár M, Valkovič P. Thyroid-induced worsening of Parkinsonian tremor resistant to drugs and subthalamic nucleus deep brain stimulation. Case Rep Neurol Med 2014; 2014: 489275
15 Mohammadzadeh N, Friedman JH. Winter cold exposure often increases tremor in Parkinson's disease. Parkinsonism Relat Disord 2024; 124 (March): 107021
16 Oertel W, Poewe W, Wolters E. et al. Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extension. Drug Saf 2008; 31 (01) 79-94
17 Gurevich TY, Shabtai H, Korczyn AD, Simon ES, Giladi N. Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia. Mov Disord 2006; 21 (10) 1663-1666
18 Maidment I, Fox C, Boustani M. Cholinesterase inhibitors for Parkinson's disease dementia. Cochrane Database Syst Rev 2006; 2006 (01) CD004747
19 Blakemore RL, MacAskill MR, Myall DJ, Anderson TJ. Volitional suppression of Parkinsonian resting tremor. Mov Disord Clin Pract 2019; 6 (06) 470-478
20 Fearon C, Lees AJ, McKinley JJ. et al. On the emergence of tremor in prodromal Parkinson's disease. J Parkinsons Dis 2021; 11 (01) 261-269
21 van der Heide A, Trenkwalder C, Bloem BR, Helmich RC. The last straw: how stress can unmask Parkinson's disease. J Parkinsons Dis 2024; 14 (04) 889-893
22 Gironell A, Kulisevsky J, Pascual-Sedano B, Pagonabarraga X. “Prodromic” tremor: prevalence and clinical correlates. Mov Disord 2007; 22 (08) 1203-1204
23 Kohat AK, Ng SYE, Wong ASY. et al. Stability of MDS-UPDRS motor subtypes over three years in early Parkinson's disease. Front Neurol 2021; 12 (704906): 704906
24 Lee JW, Song YS, Kim H, Ku BD, Lee WW. Alteration of tremor dominant and postural instability gait difficulty subtypes during the progression of Parkinson's disease: analysis of the PPMI cohort. Front Neurol 2019; 10 (471) 471
25 von Coelln R, Gruber-Baldini AL, Reich SG, Armstrong MJ, Savitt JM, Shulman LM. The inconsistency and instability of Parkinson's disease motor subtypes. Parkinsonism Relat Disord 2021; 88: 13-18
26 Deuschl G, Papengut F, Hellriegel H. The phenomenology of Parkinsonian tremor. Parkinsonism Relat Disord 2012; 18 (Suppl. 01) S87-S89
27 Abusrair AH, Elsekaily W, Bohlega S. Tremor in Parkinson's disease: from pathophysiology to advanced therapies. Tremor Other Hyperkinet Mov (N Y) 2022; 12 (01) 29
28 Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ. A clinico-pathological study of subtypes in Parkinson's disease. Brain 2009; 132 (Pt 11): 2947-2957
29 Kipfer S, Stephan MA, Schüpbach WMM, Ballinari P, Kaelin-Lang A. Resting tremor in Parkinson disease: a negative predictor of levodopa-induced dyskinesia. Arch Neurol 2011; 68 (08) 1037-1039
30 Gigante AF, Pellicciari R, Iliceto G. et al. Rest tremor in Parkinson's disease: Body distribution and time of appearance. J Neurol Sci 2017; 375: 215-219
31 van den Berg KRE, Johansson ME, Dirkx MF, Bloem BR, Helmich RC. Changes in action tremor in Parkinson's disease over time: clinical and neuroimaging correlates. Mov Disord 2025; 40 (02) 292-304
32 Hallett M. Parkinson's disease tremor: pathophysiology. Parkinsonism Relat Disord 2012; 18 (Suppl. 01) S85-S86
33 Zach H, Dirkx M, Bloem BR, Helmich RC. The clinical evaluation of Parkinson's tremor. J Parkinsons Dis 2015; 5 (03) 471-474
34 Park S, Choi JH, Yoon WT, Lee JY. Unilateral resting tremor in a thigh muscle in Parkinson's disease. Tremor Other Hyperkinet Mov (N Y) 2020; 10 (01) 44
35 Ou R, Wei Q, Hou Y. et al. Facial tremor in patients with Parkinson's disease: prevalence, determinants and impacts on disease progression. BMC Neurol 2021; 21 (01) 86
36 Jaulent P, Laurencin C, Robert H, Thobois S. Parkinson's disease revealed by a resting tongue tremor. Mov Disord Clin Pract 2015; 2 (04) 432-433
37 Gan J, Xie-Brustolin J, Gervais-Bernard H, Vallet AE, Broussolle E, Thobois S. Possible Parkinson's disease revealed by a pure head resting tremor. J Neurol Sci 2009; 279 (1-2): 121-123
38 Neuville RS, Morenkova AE. Abdominal tremor in idiopathic Parkinson's disease: a case report. Tremor Other Hyperkinet Mov (N Y) 2024; 14 (01) 4
39 Tanaka N, Hayashi T, Tsuji S, Iwata A. Abdominal tremor in Parkinson's disease. Mov Disord Clin Pract 2015; 2 (01) 104-105
40 Rajalingam R, Breen DP, Chen R. et al. The clinical significance of lower limb tremors. Parkinsonism Relat Disord 2019; 65: 165-171
41 Roze E, Coêlho-Braga MC, Gayraud D. et al. Head tremor in Parkinson's disease. Mov Disord 2006; 21 (08) 1245-1248
42 Kaski D, Bronstein AM. Ocular tremor in Parkinson's disease: discussion, debate, and controversy. Front Neurol 2017; 8 (134) 134
43 Chahine LM, Arbatti L, Hosamath A. et al. Internal tremor in people with Parkinson's disease: demographic characteristics and comorbid symptoms. Clin Park Relat Disord 2023; 9: 100229
44 Cochrane GD, Rizvi S, Abrantes A, Crabtree B, Cahill J, Friedman JH. Internal tremor in Parkinson's disease, multiple sclerosis, and essential tremor. Parkinsonism Relat Disord 2015; 21 (10) 1145-1147
45 Pasquini J, Ceravolo R, Qamhawi Z. et al. Progression of tremor in early stages of Parkinson's disease: a clinical and neuroimaging study. Brain 2018; 141 (03) 811-821
46 Gironell A, Pascual-Sedano B, Aracil I, Marín-Lahoz J, Pagonabarraga J, Kulisevsky J. Tremor types in Parkinson disease: a descriptive study using a new classification. Parkinsons Dis 2018; 2018: 4327597
47 Gigante AF, Bruno G, Iliceto G. et al. Action tremor in Parkinson's disease: frequency and relationship to motor and non-motor signs. Eur J Neurol 2015; 22 (02) 223-228
48 Dirkx MF, Zach H, Bloem BR, Hallett M, Helmich RC. The nature of postural tremor in Parkinson disease. Neurology 2018; 90 (13) e1095-e1103
49 Swinnen BEKS, de Bie RMA, Hallett M, Helmich RC, Buijink AWG. Reconstructing Re-emergent Tremor. Mov Disord Clin Pract 2023; 10 (09) 1293-1296
50 Kang SY, Song S-K, Kim J-S, Sohn YH. Unilateral standing leg tremor as the initial manifestation of Parkinson disease. J Mov Disord 2009; 2 (01) 29-32
51 Lee SY, Chung EJ, Kim YJ, Kim SJ. Dopa responsive slow orthostatic tremor in Parkinson's disease. J Mov Disord 2011; 4 (02) 82-84
52 Thomas A, Bonanni L, Antonini A, Barone P, Onofrj M. Dopa-responsive pseudo-orthostatic tremor in Parkinsonism. Mov Disord 2007; 22 (11) 1652-1656
53 Apartis E, Tison F, Arné P, Jedynak CP, Vidailhet M. Fast orthostatic tremor in Parkinson's disease mimicking primary orthostatic tremor. Mov Disord 2001; 16 (06) 1133-1136
54 Yoo SW, Choi KE, So J, Lee KS, Kim JS. Pseudo-orthostatic tremor in idiopathic Parkinson's disease: could it be re-emergent tremor?. Neurol Sci 2019; 40 (03) 621-623
55 Raethjen J, Pohle S, Govindan RB, Morsnowski A, Wenzelburger R, Deuschl G. Parkinsonian action tremor: interference with object manipulation and lacking levodopa response. Exp Neurol 2005; 194 (01) 151-160
56 Gupta HV. Re-emergent kinetic tremor in Parkinson's disease. tremor and other hyperkinetic movements. Tremor Other Hyperkinet Mov (N Y) 2016; 6: 370
57 Battista JP, Greene PE. Improvement of primary writing tremor in Parkinson's disease with carbidopa/levodopa. Tremor Other Hyperkinet Mov (N Y) 2015; 5 (345) 345
58 Mascia MM, Orofino G, Cimino P, Cadeddu G, Ercoli T, Defazio G. Writing tremor in Parkinson's disease: frequency and associated clinical features. J Neural Transm (Vienna) 2022; 129 (12) 1481-1485
59 Burne JA, Hayes MW, Fung VSC, Yiannikas C, Boljevac D. The contribution of tremor studies to diagnosis of Parkinsonian and essential tremor: a statistical evaluation. J Clin Neurosci 2002; 9 (03) 237-242
60 Hunker CJ, Abbs JH. Uniform frequency of Parkinsonian resting tremor in the lips, jaw, tongue, and index finger. Mov Disord 1990; 5 (01) 71-77
61 Farkas Z, Csillik A, Szirmai I, Kamondi A. Asymmetry of tremor intensity and frequency in Parkinson's disease and essential tremor. Parkinsonism Relat Disord 2006; 12 (01) 49-55
62 Wilken M, Bruno V, Rossi M, Ameghino L, Deuschl G, Merello M. Sensitivity and specificity of different hand positions to assess upper limb rest tremor. Mov Disord 2019; 34 (04) 575-579
63 Raethjen J, Austermann K, Witt K, Zeuner KE, Papengut F, Deuschl G. Provocation of Parkinsonian tremor. Mov Disord 2008; 23 (07) 1019-1023
64 Costanzo M, Marchet F, Leodori G. et al. Neurophysiological features of tremor during walking in Parkinson's disease. Mov Disord Clin Pract 2025; 12 (02) 226-230
65 Costanzo M, Cutrona C, Leodori G. et al. Distal upper limb tremor during walking in Parkinson's disease. Mov Disord Clin Pract 2023; 10 (08) 1198-1202
66 Schwingenschuh P, Ruge D, Edwards MJ. et al. Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study. Mov Disord 2010; 25 (05) 560-569
67 Papengut F, Raethjen J, Binder A, Deuschl G. Rest tremor suppression may separate essential from Parkinsonian rest tremor. Parkinsonism Relat Disord 2013; 19 (07) 693-697
68 Jankovic J. How do I examine for re-emergent tremor?. Mov Disord Clin Pract 2016; 3 (02) 216-217
69 Malling ASB, Morberg BM, Wermuth L, Gredal O, Bech P, Jensen BR. The influence of posture duration on hand tremor during tasks with attention-distraction in persons with Parkinson's disease. J Neuroeng Rehabil 2019; 16 (01) 61
70 Mahendran S, Bichsel O, Gassert R, Baumann CR, Imbach LL, Waldvogel D. Differentiation of Parkinson's disease tremor and essential tremor based on a novel hand posture. Clin Park Relat Disord 2022; 7: 100146
71 Uchida K, Hirayama M, Yamashita F, Hori N, Nakamura T, Sobue G. Tremor is attenuated during walking in essential tremor with resting tremor but not Parkinsonian tremor. J Clin Neurosci 2011; 18 (09) 1224-1228
72 Schneider SA, Edwards MJ, Mir P. et al. Patients with adult-onset dystonic tremor resembling Parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 2007; 22 (15) 2210-2215
73 Pintér D, Forjaz MJ, Martinez-Martin P. et al. Which scale best detects treatment response of tremor in Parkinsonism?. J Parkinsons Dis 2020; 10 (01) 275-282
74 Forjaz MJ, Ayala A, Testa CM. et al; International Parkinson and Movement Disorder Society Tremor Rating Scale Task Force. Proposing a Parkinson's disease-specific tremor scale from the MDS-UPDRS. Mov Disord 2015; 30 (08) 1139-1143
75 Rodriguez F, Krauss P, Kluckert J. et al. Continuous and unconstrained tremor monitoring in Parkinson's disease using supervised machine learning and wearable sensors. Parkinsons Dis 2024; 2024: 5787563
76 Chen L, Cai G, Weng H. et al. More sensitive identification for bradykinesia compared to tremors in Parkinson's disease based on Parkinson's KinetiGraph (PKG). Front Aging Neurosci 2020; 12 (594701): 594701
77 Crowe C, Sica M, Kenny L. et al. Wearable-enabled algorithms for the estimation of Parkinson's symptoms evaluated in a continuous home monitoring setting using inertial sensors. IEEE Trans Neural Syst Rehabil Eng 2024; 32: 3828-3836
78 Dirkx MF, Bologna M. The pathophysiology of Parkinson's disease tremor. J Neurol Sci 2022; 435: 120196
79 Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988; 318 (14) 876-880
80 Eggers C, Kahraman D, Fink GR, Schmidt M, Timmermann L. Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of FP-CIT single photon emission computed tomography. Mov Disord 2011; 26 (03) 416-423
81 Jellinger KA. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov Disord 2012; 27 (01) 8-30
82 Deutch AY, Elsworth JD, Goldstein M. et al. Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurosci Lett 1986; 68 (01) 51-56
83 Sánchez-González MA, García-Cabezas MA, Rico B, Cavada C. The primate thalamus is a key target for brain dopamine. J Neurosci 2005; 25 (26) 6076-6083
84 Helmich RC, Janssen MJR, Oyen WJG, Bloem BR, Toni I. Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Ann Neurol 2011; 69 (02) 269-281
85 Dirkx MF, den Ouden HEM, Aarts E. et al. Dopamine controls Parkinson's tremor by inhibiting the cerebellar thalamus. Brain 2017; 140 (03) 721-734
86 Helmich RC, Van den Berg KRE, Panyakaew P. et al. Cerebello-cortical control of tremor rhythm and amplitude in Parkinson's disease. Mov Disord 2021; 36 (07) 1727-1729
87 Lauro PM, Lee S, Akbar U, Asaad WF. Subthalamic-cortical network reorganization during Parkinson's tremor. J Neurosci 2021; 41 (47) 9844-9858
88 Kelley CR, Kauffman JL. Parkinsonian tremor as unstable feedback in a physiologically consistent control framework. IEEE Trans Neural Syst Rehabil Eng 2024; 32: 2665-2675
89 DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007; 64 (01) 20-24
90 Magnusson JL, Leventhal DK. Revisiting the “paradox of stereotaxic surgery”: insights into basal ganglia-thalamic interactions. Front Syst Neurosci 2021; 15: 725876
91 Hirschmann J, Abbasi O, Storzer L. et al. Longitudinal recordings reveal transient increase of alpha/low-beta power in the subthalamic nucleus associated with the onset of Parkinsonian rest tremor. Front Neurol 2019; 10 (145) 145
92 de Bie RMA, Katzenschlager R, Swinnen BEKS. et al. Update on treatments for Parkinson's disease motor fluctuations - an international Parkinson and movement disorder society evidence-based medicine review. Mov Disord 2025; 40 (05) 776-794
93 Yuill GM. Letter: Effect of levodopa on Parkinsonian tremor. BMJ 1976; 1 (6004) 283-284
94 Coppen A, Metcalfe M, Carroll JD, Morris JGL. Levodopa and L-tryptophan therapy in Parkinsonism. Lancet 1972; 1 (7752) 654-658
95 Swinnen BEKS, Frequin HL, Wiggerts Y, Espay AJ, Beudel M, de Bie RMA. Tremor is highly responsive to levodopa in advanced Parkinson's disease. Mov Disord Clin Pract 2025; 12 (01) 76-81
96 Wirth T, Ferreira F, Vijiaratnam N. et al. Parkinson's disease tremor differentially responds to levodopa and subthalamic stimulation. Mov Disord Clin Pract 2023; 10 (11) 1639-1649
97 Krack P, Pollak P, Limousin P, Benazzouz A, Benabid AL. Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease. Lancet 1997; 350 (9092) 1675
98 Frequin HL, Schouten J, Verschuur CVM. et al; LEAP Study Group. Levodopa response in patients with early Parkinson disease: further observations of the LEAP study. Neurology 2023; 100 (04) e367-e376
99 Mestre TA, Stebbins GT, Luo S, Goetz CG. Tremor is commonly responsive to levodopa along the natural history of Parkinson's disease. Mov Disord Clin Pract 2025; 12 (10) 1684-1685
100 Hellmann MA, Sabach T, Melamed E, Djaldetti R. Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease. Biomed Pharmacother 2008; 62 (04) 250-252
101 Schrag A, Keens J, Warner J. Ropinirole Study Group. Ropinirole for the treatment of tremor in early Parkinson's disease. Eur J Neurol 2002; 9 (03) 253-257
102 Navan P, Findley LJ, Jeffs JAR, Pearce RKB, Bain PG. Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on Parkinsonian tremor. Mov Disord 2003; 18 (11) 1324-1331
103 Negrotti A, Bizzarri G, Calzetti S. Long-term persistence of symptomatic effect of selegiline in Parkinson's disease. A two-months placebo-controlled withdrawal study. J Neural Transm (Vienna) 2001; 108 (02) 215-219
104 Jiménez MC, Vingerhoets FJG. Tremor revisited: treatment of PD tremor. Parkinsonism Relat Disord 2012; 18 (Suppl. 01) S93-S95
105 Fernandez HH, Robieson WZ, Chatamra K. et al. Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson's disease. NPJ Parkinsons Dis 2016; 2 (16015): 16015
106 Schrag A, Schelosky L, Scholz U, Poewe W. Reduction of Parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challenges. Mov Disord 1999; 14 (02) 252-255
107 Friedman JH, Koller WC, Lannon MC, Busenbark K, Swanson-Hyland E, Smith D. Benztropine versus clozapine for the treatment of tremor in Parkinson's disease. Neurology 1997; 48 (04) 1077-1081
108 Jansen EN. Clozapine in the treatment of tremor in Parkinson's disease. Acta Neurol Scand 1994; 89 (04) 262-265
109 Bonuccelli U, Ceravolo R, Salvetti S. et al. Clozapine in Parkinson's disease tremor. Effects of acute and chronic administration. Neurology 1997; 49 (06) 1587-1590
110 Yaw TK, Fox SH, Lang AE. Clozapine in Parkinsonian rest tremor: a review of outcomes, adverse reactions, and possible mechanisms of action. Mov Disord Clin Pract 2015; 3 (02) 116-124
111 Owen DAL, Marsden CD. Effect of adrenergic beta blockade on Parkinsonian tremor. Lancet 1966; 18 (03) 484
112 Thompson MK. Effect of oxprenolol on Parkinsonian tremor. Lancet 1972; 2 (7773) 388
113 Vas CJ. Propranolol in Parkinsonian tremor. Lancet 1966; 1 (7430) 182-183
114 Marsden CD, Parkes JD, Rees JE. Letter: propranolol in Parkinson's disease. Lancet 1974; 2 (7877) 410
115 Foster NL, Newman RP, LeWitt PA, Gillespie MM, Larsen TA, Chase TN. Peripheral beta-adrenergic blockade treatment of Parkinsonian tremor. Ann Neurol 1984; 16 (04) 505-508
116 van der Heide A, Wessel M, Papadopetraki D. et al. Propranolol reduces Parkinson's tremor and inhibits tremor-related activity in the motor cortex: a placebo-controlled crossover trial. Ann Neurol 2025; 97 (04) 741-752
117 Crosby NJ, Deane KH, Clarke CE. Beta-blocker therapy for tremor in Parkinson's disease. Cochrane Database Syst Rev 2003; 2003 (01) CD003361
118 Trosch RM, Pullman SL. Botulinum toxin A injections for the treatment of hand tremors. Mov Disord 1994; 9 (06) 601-609
119 Schneider SA, Edwards MJ, Cordivari C, Macleod WN, Bhatia KP. Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease. Mov Disord 2006; 21 (10) 1722-1724
120 Sturman MM, Vaillancourt DE, Metman LV, Bakay RAE, Corcos DM. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease. Brain 2004; 127 (Pt 9): 2131-2143
121 Katlowitz K, Ko M, Mogilner AY, Pourfar M. Effect of deep brain simulation on arm, leg, and chin tremor in Parkinson disease. J Neurosurg 2018; 131 (05) 1514-1519
122 Volonté MA, Clarizio G, Galantucci S. et al. Long term follow-up in advanced Parkinson's disease treated with DBS of the subthalamic nucleus. J Neurol 2021; 268 (08) 2821-2830
123 Millan SH, Hacker ML, Turchan M, Molinari AL, Currie AD, Charles D. Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease is not associated with increased body mass index. Parkinsons Dis 2017; 2017: 7163801
124 Faraji AH, Richardson RM. Deep brain stimulation in early Parkinson's disease may slow rest tremor progression. Neurosurgery 2019; 84 (01) E13-E14
125 Krack P, Benazzouz A, Pollak P. et al. Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov Disord 1998; 13 (06) 907-914
126 Wong JK, Viswanathan VT, Nozile-Firth KS. et al. STN versus GPi deep brain stimulation for action and rest tremor in Parkinson's disease. Front Hum Neurosci 2020; 14 (578615): 578615
127 Goto S, Nishikawa S, Mita S, Ushio Y. Impact of posterior GPI pallidotomy on leg tremor in Parkinson's disease. Stereotact Funct Neurosurg 2002; 78 (02) 64-69
128 Lozano AM, Lang AE, Hutchison WD. Pallidotomy for tremor. Mov Disord 1998; 13 (Suppl. 03) 107-110
129 Braccia A, Golfrè Andreasi N, Ghielmetti F. et al. Magnetic resonance-guided focused ultrasound thalamotomy in a prospective cohort of 52 patients with Parkinson's disease: a possible critical role of age and lesion volume for predicting tremor relapse. Mov Disord 2025; 40 (03) 478-489
130 Golfrè Andreasi N, Cilia R, Romito LM. et al. Magnetic resonance-guided focused ultrasound thalamotomy may spare dopaminergic therapy in early-stage tremor-dominant Parkinson's disease: a pilot study. Mov Disord 2022; 37 (11) 2289-2295
131 Fasano A, De Vloo P, Llinas M. et al. Magnetic resonance imaging-guided focused ultrasound thalamotomy in Parkinson tremor: reoperation after benefit decay. Mov Disord 2018; 33 (05) 848-849
132 Maamary J, Peters J, Kyle K, Barnett Y, Jonker B, Tisch S. Effective subthalamic nucleus deep brain stimulation following MRgFUS for tremor dominant Parkinson's disease. Mov Disord Clin Pract 2023; 10 (03) 486-492
133 Monteiro JDS, ESilva BB, de Oliveira RR. et al. Magnetic resonance-guided focused ultrasound ventral intermediate thalamotomy for tremor-dominant Parkinson's disease: a systematic review and meta-analysis. Neurosurg Rev 2024; 47 (01) 701
134 Paschen S, Natera-Villalba E, Pineda-Pardo JA. et al. Comparative study of focused ultrasound unilateral thalamotomy and subthalamotomy for medication-refractory Parkinson's disease tremor. Mov Disord 2025; 40 (05) 823-833
135 Schlesinger I, Benyakov O, Erikh I, Suraiya S, Schiller Y. Parkinson's disease tremor is diminished with relaxation guided imagery. Mov Disord 2009; 24 (14) 2059-2062
136 Shahien M, Elaraby A, Gamal M. et al. Physical therapy interventions for the management of hand tremors in patients with Parkinson's disease: a systematic review. Neurol Sci 2023; 44 (02) 461-470
137 Scherer M, Steiner LA, Kalia SK. et al. Single-neuron bursts encode pathological oscillations in subcortical nuclei of patients with Parkinson's disease and essential tremor. Proc Natl Acad Sci U S A 2022; 119 (35) e2205881119